F. MARC LAFORCE, M.D.; THEODORE C. EICKHOFF, M.D.
This content is PDF only. Please click on the PDF icon to access.
Pneumococcal infections have been considered as important diseases of earlier generations. Given the ease with which penicillin fights such infections, the Oslerian concept of the pneumococcus as "the captain of the men of death" (1) seems somewhat foreign and dated today. Nonetheless, infections due to Streptococcus pneumoniae remain relatively common and have become more important in recent years because of the emergence of penicillin-resistant pneumococci in clinical isolates and the introduction of a polyvalent pneumococcal vaccine.
Pneumococci contain polysaccharide capsules that are antiphagocytic; antibodies to the capsule greatly enhance phagocytosis. Thus, it seems biologically appropriate to expect that a polyvalent
LAFORCE FM, EICKHOFF TC. Pneumococcal Vaccine: The Evidence Mounts. Ann Intern Med. ;104:110–112. doi: 10.7326/0003-4819-104-1-110
Download citation file:
Published: Ann Intern Med. 1986;104(1):110-112.
Infectious Disease, Streptococcal Infections, Vaccines/Immunization.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use